Search Results - "Sandmann, Lisa"

Hepatitis D Virus Infection: Pathophysiology, Epidemiology and Treatment. Report From the Third Delta Cure Meeting 2024.

Authors: Degasperi, Elisabetta Sandmann, Lisa Wedemeyer, Heiner et al.

Source: Liver International. Jul2025, Vol. 45 Issue 7, p1-11. 11p.

Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection.

Authors: Sandmann, Lisa Ohlendorf, Valerie Ehrenbauer, Alena et al.

Source: Liver International. Feb2025, Vol. 45 Issue 2, p1-9. 9p.

Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection.

Authors: Sandmann, Lisa Degasperi, Elisabetta Port, Kerstin et al.

Source: Alimentary Pharmacology & Therapeutics. Mar2024, Vol. 59 Issue 6, p752-761. 10p.

Kinetics and Value of Hepatitis B Core-Related Antigen in Patients with Chronic Hepatitis B Virus Infection during Antiviral Treatment.

Authors: Sandmann, Lisa Bremer, Birgit Ohlendorf, Valerie et al.

Source: Viruses (1999-4915). Feb2024, Vol. 16 Issue 2, p255. 12p.

Interferon‐based treatment of chronic hepatitis D.

Authors: Sandmann, Lisa Wedemeyer, Heiner

Source: Liver International. 2023 Supplement1, Vol. 43 Issue 1, p69-79. 11p. 2 Diagrams, 2 Charts.

Kinetics and predictive value of HBcrAg, HBV RNA and anti‐HBc during bulevirtide treatment of chronic HDV‐infected patients.

Authors: Sandmann, Lisa Deterding, Katja Bremer, Birgit et al.

Source: Journal of Viral Hepatitis. Apr2023, Vol. 30 Issue 4, p283-286. 4p.

Reaching the Unreachable: Strategies for HCV Eradication in Patients With Refractory Opioid Addiction—A Real-world Experience.

Authors: Sandmann, Lisa Deppe, Julian Beier, Christoph et al.

Source: Open Forum Infectious Diseases. Aug2021, Vol. 8 Issue 8, p1-4. 4p.

HBV cure—The light at the end of the tunnel?

Authors: Sandmann, Lisa Maasoumy, Benjamin

Source: Liver International. Mar2023, Vol. 43 Issue 3, p531-533. 3p. 1 Diagram.

Experimental Drugs for the Treatment of Hepatitis D.

Authors: Sandmann, Lisa Cornberg, Markus

Source: Journal of Experimental Pharmacology. Apr2021, Vol. 13, p461-468. 8p.

Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta.

Authors: Jachs, Mathias Sandmann, Lisa Hartl, Lukas et al.

Source: Journal of Hepatology. Aug2024, Vol. 81 Issue 2, p248-257. 10p.

Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D—Authors' reply.

Authors: Sandmann, Lisa Wedemeyer, Heiner Deterding, Katja

Source: Alimentary Pharmacology & Therapeutics. May2024, Vol. 59 Issue 9, p1160-1161. 2p.

Utility of viral kinetics in HCV therapy – It is not over until it is over?

Authors: Sandmann, Lisa Manns, Michael P. Maasoumy, Benjamin

Source: Liver International. May2019, Vol. 39 Issue 5, p815-817. 3p. 1 Diagram.

Toward functional cure of hepatitis B: Is combination therapy the key?

Authors: Sandmann, Lisa^1,2 (AUTHOR)

Source: Journal of Hepatology. Jul2025, Vol. 83 Issue 1, p271-272. 2p.

Limited stability of Hepatitis B virus RNA in plasma and serum.

Authors: Ohlendorf, Valerie Bremer, Birgit Sandmann, Lisa et al.

Source: Scientific Reports. 11/7/2024, Vol. 14 Issue 1, p1-9. 9p.

Surgical Procedures in Patients Awaiting Liver Transplantation: Complications and Impact on the Liver Function.

Authors: Honerkamp, Imke Sandmann, Lisa Richter, Nicolas et al.

Source: Journal of Clinical & Experimental Hepatology. Jan2022, Vol. 12 Issue 1, p68-79. 12p.

Towards eradication of HBV: Treatment approaches and status of clinical trials.

Authors: Sandmann, Lisa Cornberg, Markus

Source: Current Opinion in Pharmacology. Oct2021, Vol. 60, p232-240. 9p.

Antiviral treatment of chronic hepatitis D virus infection: To combine or not to combine?

Authors: Sandmann, Lisa^1,2 (AUTHOR) sandmann.lisa@mh-hannover.de

Source: Journal of Hepatology. Apr2025, Vol. 82 Issue 4, p771-772. 2p.

3P and 5P models of limited value for the detection of clinically significant portal hypertension in patients with hepatitis delta.

Authors: Sandmann, Lisa Tergast, Tammo Lambert Wedemeyer, Heiner et al.

Source: Journal of Hepatology. Jul2023, Vol. 79 Issue 1, pe47-e49. 3p.

FRI-254-YI Early immune responses define Peg-IFNα-mediated treatment outcome in chronic hepatitis D virus infection.

Authors: Anim, Manfred Sandmann, Lisa Bremer, Birgit et al.

Source: Journal of Hepatology. 2025 Supplement 1, Vol. 82, pS762-S762. 1p.

SAT-117 Evaluation of Baveno VII criteria and other non-invasive tests for clinically significant portal hypertension in chronic hepatitis D.

Authors: Jachs, Mathias Sandmann, Lisa Hartl, Lukas et al.

Source: Journal of Hepatology. 2024 Supplement 1, Vol. 80, pS253-S253. 1p.